Skip to main content
Egyptian Liver Journal

Table 1 Baseline and demographic data

From: Comparative study of various glomerular filtration rate estimating equations in Egyptian patients with hepatitis C virus-related liver cirrhosis: a single-center observational study

 

HCV group (n = 120)

Control group (n = 60)

p value

Age (years)

Range

(45–68)

(42–72)

0.274

Mean ± SD

58.05 ± 5.91

56.43.1 ± 7.75

Sex (frequency)

Male

58 (48.3%)

30 (50%)

0.881

Female

62 (51.7%)

30 (50%)

Weight (kg)

Range

(67–98)

(65–95)

0.239

Mean ± SD

81.5 ± 7.31

79.53 ± 7.65

Height (cm)

Range

(154–180)

(155–175)

0.756

Mean ± SD

164.65 ± 6.51

164.2 ± 6.38

Body surface area (m2)

Range

1.92 ± 0.09

1.9 ± 0.1

0.141

Mean ± SD

(1.69–2.09)

(1.73–2.1)

BMI (kg/m2)

Range

(22.84–38.05)

(24.45–35.3)

0.435

Mean ± SD

30.19 ± 3.49

29.59 ± 3.35

Serum creatinine (mg/dl)

Range

(0.78–2.3)

(0.45–0.8)

< 0.001*

Mean ± SD

1.31 ± 0.35

0.64 ± 0.1

Blood Urea (mg/dl)

Range

(1.38–137.23)

(18–40)

< 0.001*

Mean ± SD

44.83 ± 22.06

27.03 ± 5.32

Serum cystatin C (μg/L)

Range

(0.9–4.2)

(0.55–1.1)

< 0.001*

Mean ± SD

1.79 ± 0.61

0.72 ± 0.11

Serum sodium (mEq/L)

Range

(128–153)

(134–145)

0.155

Mean ± SD

138.9 ± 4.34

137.67 ± 2.55

Serum potassium (mEq/L)

Range

(3–6)

(3.40–4.50)

0.005*

Mean ± SD

4.06 ± 0.47

3.85 ± 0.21

Fasting plasma glucose (mg/dl)

Range

(65–110)

(75–100)

0.155

Mean ± SD

83.22 ± 11.55

86 ± 6.78

2 h postprandial plasma glucose (mg/dl)

Range

(3.80–140)

(96–120)

0.002*

Mean ± SD

115.91 ± 23.3

105.57 ± 6.16

RBCs (× 106/mm3)

Range

(2.25–5.5)

(3.9–6.2)

< 0.001*

Mean ± SD

3.61 ± 0.6

5.17 ± 0.59

HB (g/dl)

Range

(5.8–15.1)

(8.6–15)

< 0.001*

Mean ± SD

9.89 ± 1.79

12.6 ± 1.43

aPlatelets (× 103/mm3)

Median

113.5

330.5

< 0.001*

IQR

(92–180.5)

(289–361)

WBCs (× 103/mm3)

Range

(2.90–11.2)

(3.4–8.4)

0.554

Mean ± SD

6.24 ± 2.03

6 ± 1.4

aTotal bilirubin (mg/dl)

Median

1.5

0.4

< 0.001*

IQR

(1.1–2.4)

(0.3–0.4)

aDirect bilirubin (mg/dl)

Median

0.8

0.2

< 0.001*

IQR

(0.4–1)

(0.2–0.3)

aAST (IU/L)

Median

54.5

22

< 0.001*

IQR

(39.4–84)

(18–24)

aALT (IU/L)

Median

44.5

23.5

< 0.001*

IQR

(32.5–67.2)

(22–27)

Albumin (g/dl)

Range

(1.5–4.85)

(4.18–4.9)

< 0.001*

Mean ± SD

2.63 ± 0.64

4.56 ± 0.24

INR

Range

(1.03–2.85)

(0.98–1.02)

< 0.001*

Mean ± SD

1.63 ± 0.53

1 ± 0.01

Creatinine clearance (ml/min per 1.73 m2)

Range

(20–87.8)

(85–138)

< 0.001*

Mean ± SD

51.39 ± 16.05

113.9 ± 12.74

Cockcroft-Gault formula (ml/min per 1.73 m2)

Range

(33–108)

(69–202)

< 0.001*

Mean ± SD

70.33 ± 20.4

121.17 ± 38.29

MDRD (ml/min per 1.73 m2)

Range

(25–98)

(88–225)

< 0.001*

Mean ± SD

52.78 ± 15.84

126.83 ± 29.14

CKD-EPI (ml/min per 1.73 m2)

Range

(26–95)

(103–155)

< 0.001*

Mean ± SD

56.1 ± 17.24

121.4 ± 12.04

CKD-EPI creatinine-cystatin C (ml/min per 1.73 m2)

Range

(16–79)

(97–161)

< 0.001*

Mean ± SD

45.95 ± 14.82

123.77 ± 14.52

CKD-EPI cystatin C (ml/min per 1.73 m2)

Range

(11–87)

(78–164)

< 0.001*

Mean ± SD

40.55 ± 16.68

119.57 ± 16.86

  1. Independent sample t test for parametric quantitative data between the two groups
  2. *Significant difference at p value < 0.05
  3. aMann–Whitney test for non-parametric quantitative data between the two groups. Chi square test for qualitative data between the two groups
Back to article page